dc.creator | Tomić, Mirko | |
dc.creator | Kundakovic, M | |
dc.creator | Butorovic, B | |
dc.creator | Vasilev, V | |
dc.creator | Dragovic, D | |
dc.creator | Roglić, Goran | |
dc.creator | Ignjatovic, DJ | |
dc.creator | Šoškić, Vukić | |
dc.creator | Kostić Rajačić, Slađana | |
dc.date.accessioned | 2019-05-02T09:56:27Z | |
dc.date.available | 2019-05-02T09:56:27Z | |
dc.date.issued | 2003 | |
dc.identifier.issn | 0031-7144 | |
dc.identifier.uri | https://cer.ihtm.bg.ac.rs/handle/123456789/2823 | |
dc.publisher | Govi-Verlag Gmbh, Eschborn | |
dc.rights | restrictedAccess | |
dc.source | Pharmazie | |
dc.title | Pharmacological evaluation of 5-{2-[4-(2-methoxy-phenyl)-piperazin-1-yl]-ethyl}-1,3-dihydro-benz-imidazole-2-thione as a potential atypical antipsychotic agent | en |
dc.type | article | |
dc.rights.license | ARR | |
dcterms.abstract | Роглић, Горан; Соскиц, В; Томиц, М; Кундаковиц, М; Буторовиц, Б; Василев, В; Драговиц, Д; Игњатовиц, ДЈ; Костић Рајачић, Слађана; | |
dc.citation.volume | 58 | |
dc.citation.issue | 9 | |
dc.citation.spage | 677 | |
dc.citation.epage | 678 | |
dc.citation.other | 58(9): 677-678 | |
dc.citation.rank | M23 | |
dc.identifier.pmid | 14558499 | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_cherry_149 | |
dc.identifier.scopus | 2-s2.0-0141619390 | |
dc.identifier.wos | 000185425100020 | |
dc.type.version | publishedVersion | |